Inovio announces common stock and warrants offering, no amount given

Inovio (INO) Pharmaceuticals announced that it intends to offer and sell shares of its common stock, accompanying Series A warrants and Series B warrants to purchase shares of its common stock, in an underwritten public offering. All of the securities in the proposed offering will be sold by Inovio. Piper Sandler & Co. is acting as sole book-running manager for the offering.